Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sara García-Alonso
Resistance to the Antibody–Drug Conjugate T-Dm1 Is Based in a Reduction in Lysosomal Proteolytic Activity
Cancer Research
Cancer Research
Oncology
Related publications
T-Dm1, a Novel Antibody-Drug Conjugate, Is Highly Effective Against Uterine and Ovarian Carcinosarcomas Overexpressing HER2
Clinical and Experimental Metastasis
Medicine
Cancer Research
Oncology
Blocking the Proteolytic Activity of Zymogen Matriptase With Antibody-Based Inhibitors
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Studies on Antibody-Anticancer Drug Conjugate
Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
Preclinical Evaluation of a GFRA1 Targeted Antibody-Drug Conjugate in Breast Cancer
Oncotarget
Oncology
Successful Rapid Desensitization to the Antibody–drug Conjugate Brentuximab Vedotin in a Patient With Refractory Hodgkin Lymphoma
Journal of Oncology Pharmacy Practice
Medicine
Oncology
Pharmacology
Antibody–Drug Conjugate Hits Elusive HER2 + Breast Tumors
Cancer Discovery
Oncology
Tumor Stroma–targeted Antibody-Drug Conjugate Triggers Localized Anticancer Drug Release
Journal of Clinical Investigation
Medicine
Enfortumab Vedotin Antibody-Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models
Cancer Research
Cancer Research
Oncology
Functional Relevance of in Vivo Half Antibody Exchange of an IgG4 Therapeutic Antibody-Drug Conjugate
PLoS ONE
Multidisciplinary